Dimethyl itaconate induces long-term innate immune responses and confers protection against infection

Ferreira, A.V.; Kostidis, S.; Groh, L.A.; Koeken, V.A.C.M.; Bruno, M.; Baydemir, I.; Kilic, G.; Bulut, O.; Andriopoulou, T.; Spanou, V.; Synodinou, K.D.; Gkavogianni, T.; Moorlag, S.J.C.F.M.; Bree, L.C. de; Mourits, V.P.; Matzaraki, V.; Koopman, W.J.H.; Veerdonk, F.L. van de; Renieris, G.; Giera, M.; Giamarellos-Bourboulis, E.J.; Novakovic, B.; Domínguez-Andrés, J.

doi:doi:10.1016/j.celrep.2023.112658

Itaconate is an immunomodulatory metabolite produced by immune cells under microbial stimulation and certain pro-inflammatory conditions and triggers antioxidant and anti-inflammatory responses. We show that dimethyl itaconate, a derivative of itaconate previously linked to suppression of inflammation and widely employed as an alternative to the endogenous metabolite, can induce long-term transcriptional, epigenomic, and metabolic changes, characteristic of trained immunity. Dimethyl itaconate alters glycolytic and mitochondrial energetic metabolism, ultimately leading to increased responsiveness to microbial ligand stimulation. Subsequently, mice treated with dimethyl itaconate present increased survival to infection with Staphylococcus aureus. Additionally, itaconate levels in human plasma correlate with enhanced ex vivo pro-inflammatory cytokine production. Collectively, these findings demonstrate that dimethyl itaconate displays short-term anti-inflammatory...Show more Itaconate is an immunomodulatory metabolite produced by immune cells under microbial stimulation and certain pro-inflammatory conditions and triggers antioxidant and anti-inflammatory responses. We show that dimethyl itaconate, a derivative of itaconate previously linked to suppression of inflammation and widely employed as an alternative to the endogenous metabolite, can induce long-term transcriptional, epigenomic, and metabolic changes, characteristic of trained immunity. Dimethyl itaconate alters glycolytic and mitochondrial energetic metabolism, ultimately leading to increased responsiveness to microbial ligand stimulation. Subsequently, mice treated with dimethyl itaconate present increased survival to infection with Staphylococcus aureus. Additionally, itaconate levels in human plasma correlate with enhanced ex vivo pro-inflammatory cytokine production. Collectively, these findings demonstrate that dimethyl itaconate displays short-term anti-inflammatory characteristics and the capacity to induce long-term trained immunity. This pro-and anti-inflammatory dichotomy of dimethyl itaconate is likely to induce complex immune responses and should be contemplated when considering itaconate derivatives in a therapeutic context.
Show less

Leiden University Scholarly Publications

View statistics

Documents

In Collections

Dimethyl itaconate induces long-term innate immune responses and confers protection against infection